To evaluate the implementation of Mobile Integrated Health (MIH) programs for patients discharged after hospitalization for heart failure (HF) using the RE-AIM framework.
Approach:
Qualitative Investigation: Conducted within the MIGHTy-Heart trial, focusing on MIH program implementation across two large urban health systems.
RE-AIM Framework: Utilized to assess Reach, Effectiveness, Adoption, Implementation, and Maintenance of the MIH intervention.
Stakeholder Interviews: Gathered qualitative data from patients and healthcare professionals to evaluate adoption, implementation, and maintenance.
Key Findings:
MIH programs have potential to reduce ED transports, 30-day hospital readmissions, and total healthcare costs.
There is substantial variation among MIH programs in clinical protocols, telehealth utilization, and care coordination.
Qualitative data revealed barriers and facilitators to MIH program delivery and sustainability.
Interpretation:
The study highlights the need for standardized evaluation of MIH programs to reconcile differences in patient and clinician enthusiasm with variable clinical outcomes.
Limitations:
Limited research exists on the effectiveness of MIH programs compared to traditional care models.
Variability in MIH program implementation may affect generalizability of findings.
Conclusion:
An integrated implementation-effectiveness analysis is necessary to identify valuable MIH components and suitable populations for their use.
A nationwide German claims analysis found lower initiation of guideline-recommended sodium-glucose cotransporter-2 inhibitors among women and patients living in lower-income municipalities.
The proposed framework classified 30% of patients as high or extreme risk, compared with 12% classified as having severe or greater tricuspid regurgitation under established grading schemes.
